Clonmel Healthcare is delighted to announce the launch of Cinacalcet Clonmel 30mg, 60mg and 90mg Film-coated Tablets.
Adults
Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy.
Paediatric population
Treatment of secondary hyperparathyroidism (HPT) in children aged 3 years and older with end-stage renal disease (ESRD) on maintenance dialysis therapy in whom secondary HPT is not adequately controlled with standard of care therapy.
Full prescribing information is available on request or alternatively please go to www.clonmel-health.ie. Product is subject to medical prescription.
Please contact Clonmel Healthcare on 01-6204000 if you require any additional information.
PA 126/306/001-003. PA Holder: Clonmel Healthcare Ltd., Clonmel, Co. Tipperary. Date prepared: April 2020. 2020/ADV/CIN/034H
